Enzymicals Partners with Proteineer to Unlock Unprecedented Access to Protein Sequences and Genomic Data

12. July 2024

We are pleased to announce a strategic collaboration between Enzymicals AG and Proteineer GmbH ! This partnership revolutionizes our ability to support your enzyme discovery and development projects.

🔍 Key Benefits:
• Access Over 4 Billion Protein Sequences and 15+ Petabytes of Genomic Dark Matter
• Integrated Search, Structures, Docking and massive Metadata and supported by newest AI Models
• Additional Services for creating and testing novel enzyme panels with FTO or novel patent positions

✨ Why This Matters: Imagine instantly testing natures full potential of sequences with our screening service. Promising hits can quickly be transferred into process development and scale-up procedures. Evaluate your enzymatic synthesis ideas and perform techno-economic viability studies at kilogram scale effortlessly!